Protein Complex for Intracellular Delivery via Segmentation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for delivering biologically active macromolecules, such as proteins and peptides, into cells are hindered by cell membrane permeability issues, stability concerns, and limited targeting ability, leading to low efficacy and instability in vivo.

Innovation Solution

A protein complex comprising an in vitro stabilization protein like ubiquitin, a membrane translocation sequence domain, a biologically active molecule, an in vivo stabilization protein such as serum albumin binding peptide, and a nucleus-cytoplasm signal domain, which facilitates efficient intracellular delivery and stability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If biologically active macromolecules (proteins, peptides) are used as therapeutic agents, then physiological selectivity and efficacy are improved, but cell membrane permeability deteriorates

Engineering Contradiction:
Improvephysiological selectivity and efficacyVSAvoidcell membrane permeability
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The protein is divided into functional domains: a cell permeable domain (first region) that facilitates membrane crossing, and a biologically active domain (second region) that performs the therapeutic function inside the cell. This segmentation allows the protein to overcome the membrane barrier while maintaining its biological activity.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The first region acts as an intermediary or delivery vehicle that mediates the transport of the biologically active second region across the cell membrane. This intermediary domain enables the macromolecule to penetrate the membrane without compromising the activity of the functional region.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of operation

If delivery systems using short peptides are developed, then cell permeability is improved, but in vitro and in vivo stability deteriorates

Engineering Contradiction:
Improvecell permeabilityVSAvoidin vitro and in vivo stability
Core Design Contradiction:
Ease of operationVSStability of the object's composition

Solution Approach 1:

The invention creates a composite protein structure combining a cell permeable domain with a biologically active domain. This composite design integrates the membrane-crossing capability of short peptides with the stability and functionality of full-length proteins, achieving both permeability and stability.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The invention merges the beneficial characteristics of short peptides (cell permeability) with those of stable proteins (structural integrity and activity). By combining these two functional elements into a single protein construct, the invention achieves both delivery capability and stability.

Inventive Principle:
Principle #5Merging (Combining)

3Reliability

If biologically active macromolecules are delivered into cells, then therapeutic efficacy is improved, but delivery efficiency deteriorates due to cell membrane barrier

Engineering Contradiction:
Improvetherapeutic efficacyVSAvoiddelivery efficiency
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The protein is segmented into a delivery-specific first region and a functional second region. This segmentation ensures that the delivery function is optimized for membrane penetration while the functional region maintains high therapeutic efficacy, thereby improving overall delivery efficiency.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention modifies the structural parameters of the protein by introducing specific domains with optimized properties for membrane interaction. The first region has parameters (amino acid sequence, structure) specifically tuned for efficient membrane crossing, enhancing delivery efficiency.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The protein complex effectively delivers biologically active molecules into cells, enhancing their stability and functionality, as demonstrated by its ability to suppress cancer cell growth in various cell lines, while maintaining solubility and avoiding immunogenicity.

Implementation Method 1

a membrane translocation sequence domain, a biologically active molecule

Methodology Applied
Scientific EffectPermeation: Permeation

Implementation Method 2

an in vitro stabilization protein that is a ubiquitin (Ub), a Ub-like protein

Methodology Applied
Scientific EffectProtein-protein interaction:

Implementation Method 3

an in vivo stabilization protein that is a serum albumin binding peptide

Methodology Applied
Scientific EffectProtein-protein interaction:

Data Source

PatentEP2559441B1Protein complex for intracellular delivery and uses thereof
Publication Date: 2021.07.21 SAMSUNG ELECTRONICS CO LTD
  • EP2559441B1 patent drawingFigure 1
  • EP2559441B1 patent drawingFigure 2(a)~2(b)
  • EP2559441B1 patent drawingFigure 3

AI summary

A protein complex for intracellular delivery and a use thereof. The protein complex for intracellular delivery and a method of delivering a biologically active molecule into a cell by using the protein complex enable an effective delivery of a biologically active molecule.